Omep Uno (Omeprazole)

Omeprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related disorders.

• Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the esophageal lining.
• Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion.
• Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.
• NSAID‑induced gastropathy: helps prevent ulcer formation in at‑risk patients.

• Omeprazole is a reversible covalent inhibitor of the gastric H+/K+‑ATPase enzyme (the proton pump) located in the parietal cells of the stomach. By binding to the pump's cysteine residues, it blocks the final step of acid secretion, leading to a prolonged increase in gastric pH and reduced acidity in the stomach lumen.

Omeprazole is generally well‑tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild, transient headache.
• Diarrhea: loose stools, usually self‑limiting.
• Abdominal pain: mild discomfort or cramping.
• Nausea: occasional feeling of queasiness.
• Flatulence: increased intestinal gas.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis presenting with watery diarrhea.
• Acute interstitial nephritis: kidney inflammation with reduced urine output.
• Severe hypersensitivity: rash, angio‑edema, or anaphylaxis.
• Osteoporotic fractures: increased risk of hip, spine or wrist fractures with long‑term use.
• Vitamin B12 deficiency: reduced absorption leading to anemia.
• Hepatotoxicity: elevated liver enzymes or hepatitis.

When prescribing Omeprazole, clinicians should consider several safety aspects.

• Assess renal function: adjust use in severe renal impairment.
• Review concomitant medications: potential for drug‑drug interactions.
• Monitor long‑term use: evaluate need for continued therapy after several months.
• Pregnancy and lactation: weigh benefits against potential risks.
• Elderly patients: start with the lowest effective dose and monitor.
• Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole may interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

• Clopidogrel: reduces the antiplatelet effect .
• Atorvastatin: increased plasma concentration may raise risk of myopathy.
• Warfarin: may enhance anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely)

• Digoxin: higher serum levels possible.
• Methotrexate: reduced renal clearance may increase toxicity.
• Phenytoin: altered metabolism may affect seizure control.
• Ketoconazole: decreased absorption due to higher gastric pH.
• Iron‑relevant